January 23, 2026

Iovance Biotherapeutics, Inc. (IOVA) Stock Analysis: Unpacking a Potential 210% Upside Amidst Biotech Innovations

Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a trailblazer in the biotechnology sector, has captured investor attention with a notable potential upside of 210.41%, according to recent analyst..

iRadimed Corporation (IRMD): Investor Outlook on a Medical Device Innovator with a 15.7% Revenue Growth

iRadimed Corporation (NASDAQ: IRMD), a prominent player in the healthcare sector, specializes in developing MRI-compatible medical devices. Headquartered in Orlando, Florida, the company has carved out..

Butterfly Network, Inc. (BFLY) Stock Analysis: Examining the Potential 7.71% Upside in a Bullish Medical Device Market

Butterfly Network, Inc. (NASDAQ: BFLY) is making waves in the healthcare sector, particularly in the niche of medical devices. With a current market capitalization of $1.19..

Arcus Biosciences (RCUS): Investor Outlook Reveals 43% Upside Potential Amid Biotech Innovations

Arcus Biosciences, Inc. (NASDAQ: RCUS), a clinical-stage biopharmaceutical company, has been making waves in the biotechnology sector with its promising cancer therapies. With a current market..

Fulgent Genetics, Inc. (FLGT) Stock Analysis: A Look at Potential 19.51% Upside in the Healthcare Sector

Fulgent Genetics, Inc. (NASDAQ: FLGT) is positioning itself as a promising player in the healthcare sector, specifically within the diagnostics and research industry. Headquartered in El..

Avadel Pharmaceuticals (AVDL) Stock Analysis: Navigating Potential Amidst a 54.9% Revenue Growth Surge

Avadel Pharmaceuticals plc (NASDAQ: AVDL) has been capturing the attention of investors within the healthcare sector, specifically those focusing on specialty and generic drug manufacturers. This..

Phibro Animal Health Corporation (PAHC) Stock Analysis: Navigating Growth and Valuation with a 3.34% Potential Upside

Phibro Animal Health Corporation (NASDAQ: PAHC) stands out in the healthcare sector as a key player in the drug manufacturers – specialty and generic industry. With..

Spyre Therapeutics, Inc. (SYRE) Stock Analysis: A Biotech Gem with 65% Upside Potential

Spyre Therapeutics, Inc. (NASDAQ: SYRE), a burgeoning name in the healthcare sector, is capturing the attention of investors with its promising prospects in the biotechnology industry...

Nutex Health Inc. (NUTX) Stock Report: Exploring a 56.82% Potential Upside in the Booming Healthcare Sector

Nutex Health Inc. (NASDAQ: NUTX) has emerged as a noteworthy player in the healthcare sector, particularly within the medical care facilities industry. With a market capitalization..

Beta Bionics, Inc. (BBNX) Stock Analysis: A 92.67% Upside Potential for Innovative Diabetes Solutions

For investors seeking exposure to the cutting-edge healthcare sector, Beta Bionics, Inc. (NASDAQ: BBNX) offers a compelling opportunity with significant growth potential. This commercial-stage medical device..

Intellia Therapeutics (NTLA) Stock Analysis: Exploring a 40% Upside Potential in Gene Editing Innovations

Intellia Therapeutics, Inc. (NASDAQ: NTLA), a trailblazer in the biotechnology sector, is captivating investor attention with its promising gene editing technologies and substantial growth potential. Headquartered..

CureVac N.V. (CVAC) Investor Outlook: Navigating the Biotechnology Terrain Amidst Strategic Acquisitions

CureVac N.V. (NASDAQ: CVAC), a prominent player in the biotechnology sector, has been navigating a complex landscape characterized by significant innovation and strategic shifts. As of..

Geron Corporation (GERN) Stock Analysis: Unveiling a 155% Upside Potential in Biotech

Geron Corporation (NASDAQ: GERN), a burgeoning name in the biotechnology sector, has recently captured the attention of investors with its significant upside potential. With a current..

Pharvaris N.V. (PHVS) Stock Analysis: Navigating a 65% Upside in Biotech Innovations

Pharvaris N.V. (PHVS), a Swiss-based biopharmaceutical company, has emerged as a compelling player in the biotechnology sector, focusing on developing therapies for rare diseases. With a..

Embecta Corp. (EMBC) Stock Analysis: Unlocking 37% Potential Upside in the Healthcare Sector

Embecta Corp. (NASDAQ: EMBC), a prominent player in the healthcare sector, is gaining attention from investors due to its promising potential for a 37.97% upside. Specializing..

Akebia Therapeutics, Inc. (AKBA) Stock Analysis: A 275% Potential Upside That Investors Can’t Ignore

For investors keen on tapping into the dynamic world of healthcare innovation, Akebia Therapeutics, Inc. (NASDAQ: AKBA) presents a particularly compelling opportunity. With its focus on..

Nurix Therapeutics, Inc. (NRIX) Stock Analysis: Exploring a 52.60% Potential Upside in the Biotech Arena

Nurix Therapeutics, Inc. (NASDAQ: NRIX), a promising player in the biotechnology sector, is capturing investor attention with its potential for significant upside. With a market capitalization..

HealthStream, Inc. (HSTM) Stock Analysis: Uncovering a 51% Upside Potential for Investors

HealthStream, Inc. (NASDAQ: HSTM), a prominent player in the Health Information Services industry, stands out as a compelling investment opportunity for those looking to navigate the..

Niagen Bioscience, Inc. (NAGE) Stock Analysis: Unveiling a 151% Potential Upside in the Biotechnology Sector

For investors seeking promising opportunities in the biotechnology sector, Niagen Bioscience, Inc. (NAGE) presents an intriguing prospect with a substantial potential upside. Listed in the healthcare..

Zymeworks Inc. (ZYME) Stock Analysis: Strong Buy Ratings and a Promising 51% Upside Potential

Zymeworks Inc. (NASDAQ: ZYME) stands out as a formidable player in the biotech sector, driven by its innovative approach to cancer and autoimmune disease therapies. With..

Search

Funds

January 23, 2026

Search

Funds

January 23, 2026

FTSE 100

Funds